DCI Indonesia Tbk vs Kalbe Farma Tbk — how do they compare? DCI Indonesia Tbk trades at Rp198,675 (market cap 473.71T, 1K 24h volume), while Kalbe Farma Tbk trades at Rp705 (market cap 34.17T, 156.61M 24h volume). The key difference: DCI Indonesia Tbk is far larger — about 13.9× Kalbe Farma Tbk's market cap, and Kalbe Farma Tbk is more actively traded (156.61M versus 1K). Which is the better fit depends on your goals.
| DCII | KLBF | |
|---|---|---|
Market Cap | 473.71T | 34.17T |
Volume | 1K | 156.61M |
Lot | 10 | 1.57M |
Turnover | 194.12M | 111.23B |
Average Price | 194,120 | 710.21 |
Value | 194.12M | 111.23B |
Indicative Equilibrium Price | 199,000 | 705 |
Indicative Equilibrium Volume | 1 | 56.1K |
Trailing returns across standard periods
Latest headlines on both assets
PT DCI Indonesia Tbk (the Company) was established in Indonesia based on Notarial Deed No. 143 of Buntario Tigris, S.H., S.E., M.H., on July 18, 2011. The Company started its commercial operations in 2013. The Company parent entity and ultimate controlling party is DCI International Holding Pte. Ltd., Singapore.
Read more on DCII →PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →